Results 161 to 170 of about 16,210 (241)

A visible assay for evaluating the inhibitory activity of drug and antibody against HBV infection. [PDF]

Microbiol Spectr
Yan H, Li Y, Liu C, Guo H, Liu Y, Wang H, Ge X, Zhang Z, Ju B.   +8 more
europepmc   +1 more source

Emerging antiviral drugs and immunotherapy for chronic hepatitis B and associated liver disease. [PDF]

Front Immunol
Zhu C, Yang J, Sheng Y, Fang M.
europepmc   +1 more source

Evaluation of the efficacy of plan adaptation in stereotactic body proton therapy for pancreatic cancer. [PDF]

J Appl Clin Med Phys
Matsuo Y, Uchinami Y, Katoh N, Hashimoto T, Aoyama H, Nakazato K, Matsuura T, Miyamoto N, Takao S.   +8 more
europepmc   +1 more source

Relative Biological Effectiveness of Carbon Ion Versus Photon Radiation Therapy for Acute Radiation-Induced Esophagitis in Locally Advanced Non-small Cell Lung Cancer Derived From Normal Tissue Complication Probability Modeling. [PDF]

Adv Radiat Oncol
Liu Y, Ma N, Li Y, Mi J, Fan X, Chen J, Chen J, Guo Y, Liu X, Su Y, Mao J, Jiang G, Wu K.   +12 more
europepmc   +1 more source

Effects of bulevirtide on atherosclerosis in an ApoE-deficient mouse model. [PDF]

PLoS One
Rusnak J, Delcheva V, Theile D, Blank A, Frey N, Preusch MR.   +5 more
europepmc   +1 more source

A prescription-free, radiobiology-based framework for automated VMAT planning: A feasibility study in primary prostate cancer radiotherapy. [PDF]

Med Phys
Kuhn D, Spohn SKB, Zamboglou C, Grosu AL, Baltas D, Sachpazidis I.   +5 more
europepmc   +1 more source

Improved organs-of-interest dose reduction potential with intensity modulated proton therapy and breath-hold in mediastinal lymphoma. [PDF]

Phys Imaging Radiat Oncol
Ta BDP, Canters RAM, van der Klugt K, Vilches-Freixas G, Kneepkens E, Vereijken F, Cobben M, van den Bosch M, Lubken I, Stultiens C, Velders M, Verstappen T, Tholen G, Niezink AGH, De Ruysscher DKM, Berbée M.   +15 more
europepmc   +1 more source

A multi-toxicity deep learning approach for normal tissue complication probability modelling in head and neck cancer patients receiving radiotherapy. [PDF]

Radiother Oncol
MacRae DC, van der Hoek L, de Vette SPM, Neh H, Moreno AC, Fuller CD, Langendijk JA, Valdenegro-Toro MA, Sijtsema NM, van Ooijen PMA, van Dijk LV.   +10 more
europepmc   +1 more source

Reirradiation treatment effects in the clinic (ReTEC) proposal - proof of concept based on spinal cord dose tolerance for reirradiation with stereotactic body radiotherapy. [PDF]

J Appl Clin Med Phys
Grimm J, Mahadevan A, Obayomi-Davies O, Soltys SG, Sahgal A, Redmond KJ, Milano MT, Tomé WA, Brooks K, Dodd S, Vargo JA, Subedi G, Xue J, Ebid B, Ehret F, Rhieu BA, Fürweger C, Grimm R, Muacevic A, Moiseenko V, Kalnicki S, McLaughlin M, Kleinberg LR, Adler JR, Gibbs IC.   +24 more
europepmc   +1 more source